ARISE Plus organised 2 discussion sessions on ASEAN Pharmaceutical Regulatory Policy (APRP) for representatives of the Pharmaceutical Product Working Group(PPWG) and the ASEAN Health Cluster 3 (AHC 3). The two ASEAN bodies representing Member States’ interest in the economic and health aspects of the pharmaceutical sector are leading the development of comprehensive market integration of the pharmaceutical sector. The virtual event was held in 2 sessions on 8th & 15th October, 2021 to develop the draft APRP and propose this for formal adoption by ASEAN. This event was the 4th round of the of deliberations on the APRP and have been ongoing since December 2020.
After extensive and serious discussions, the representatives of the PPWG and the AHC 3 developed a consensus on the draft APRP and have proposed this to be progressed through the formal process to be endorsed by the ASEAN Health and Economic Ministers.
For more details, please visit: Discussion on the ASEAN Pharmaceutical Regulatory Policy (APRP)